Letter to the Editor
1. Braga CYY, Rivetti LA, Stella FP. Efetividade e segurança dos stents farmacológicos em um serviço de cardiologia em Curitiba-PR. Arq Bras Cardiol. 2010;95(1):3-11.
2. Campos CAHM, Ribeiro EE, Lemos PA, Falcão JL, Spadaro AG, Kajita LJ, et al. Perfil de segurança dos stents farmacológicos nas síndromes coronárias agudas: dados do Registro INCOR. Rev Bras Cardiol Invas. 2008;16(3):289-94.
References
Acetylsalicylic Acid and Clopidogrel in the Prevention of Stent
Thrombosis
Mariana Menegotto, Eduardo Maffini da Rosa, Marina Bertoni Guerra
Universidade de Caxias do Sul - UCS, Caxias do Sul, RS - BrazilMailing address: Mariana Menegotto •
Rua Travessao Solferino, 1156 - Cruzeiro - Caxias do Sul, RS - Brazil E-mail: [email protected]
Manuscript received October 27, 2011; revised mansucript received January 17, 2011; accepted January 17, 2011.
Keywords
Drug-eluting stents; aspirin/administration & dosage; clopidogrel; thrombosis.
Our team of studies in Ischemic Heart Disease congratulates the authors for the article “Effectiveness and Safety of Drug-Eluting stents in a Cardiology Department in Curitiba - PR”¹ and the results obtained at their department.
It is known that the occurrence of stent thrombosis has often catastrophic consequences, such as acute vessel occlusion, or even sudden death². Stent thrombosis is a topic that interests us, especially in the way we manage late thrombosis in drug-eluting stents. Therefore, we would like to know the authors’ opinion about the routine use of acetylsalicylic acid and clopidogrel after the first year of drug-eluting stent implantation in order to avoid events due to late stent thrombosis.
